Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Alkermes (ALKS) over the last 15 years, with Sep 2025 value amounting to $24.7 million.

  • Alkermes' Share-based Compensation rose 9.46% to $24.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.2 million, marking a year-over-year decrease of 8.40%. This contributed to the annual value of $96.6 million for FY2024, which is 4.23% down from last year.
  • Per Alkermes' latest filing, its Share-based Compensation stood at $24.7 million for Q3 2025, which was down 1.21% from $25.0 million recorded in Q2 2025.
  • Over the past 5 years, Alkermes' Share-based Compensation peaked at $32.8 million during Q1 2024, and registered a low of $15.5 million during Q1 2021.
  • In the last 3 years, Alkermes' Share-based Compensation had a median value of $23.9 million in 2023 and averaged $24.5 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first spiked by 44.66% in 2024, then tumbled by 30.36% in 2025.
  • Quarterly analysis of 5 years shows Alkermes' Share-based Compensation stood at $19.0 million in 2021, then spiked by 39.24% to $26.5 million in 2022, then decreased by 2.42% to $25.8 million in 2023, then dropped by 19.72% to $20.7 million in 2024, then increased by 9.46% to $24.7 million in 2025.
  • Its last three reported values are $24.7 million in Q3 2025, $25.0 million for Q2 2025, and $22.8 million during Q1 2025.